0000950170-23-071875.txt : 20231220
0000950170-23-071875.hdr.sgml : 20231220
20231220160527
ACCESSION NUMBER: 0000950170-23-071875
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231219
FILED AS OF DATE: 20231220
DATE AS OF CHANGE: 20231220
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kohli Prashant
CENTRAL INDEX KEY: 0001946739
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35776
FILM NUMBER: 231501373
MAIL ADDRESS:
STREET 1: 206 CAMBRIDGE LANE
CITY: NEWTOWN
STATE: PA
ZIP: 13940
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Acasti Pharma Inc.
CENTRAL INDEX KEY: 0001444192
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: A8
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 103 CARNEGIE CENTER
STREET 2: SUITE 300
CITY: PRINCETON
STATE: NJ
ZIP: 08540
BUSINESS PHONE: 609-649-9272
MAIL ADDRESS:
STREET 1: 103 CARNEGIE CENTER
STREET 2: SUITE 300
CITY: PRINCETON
STATE: NJ
ZIP: 08540
4
1
ownership.xml
4
X0508
4
2023-12-19
0001444192
Acasti Pharma Inc.
ACST
0001946739
Kohli Prashant
103 CARNEGIE CENTER
SUITE 300
PRINCETON
NJ
08540
true
true
false
false
Chief Executive Officer
false
Stock Options (Right to Buy)
2.125
2023-12-19
4
A
false
41668
0
A
2033-12-19
Class A Common Shares
41668
41668
D
Stock options granted on 12/19/2023 under the Acasti Pharma Stock Option Plan, which fully vested upon grant.
/s/ Prashant Kohli
2023-12-20